The effects of quality improvement for depression in primary care at nine years: results from a randomized, controlled group-level trial.

The RAND Corporation, 1776 Main Street, Santa Monica, CA 90401, USA.
Health Services Research (Impact Factor: 2.49). 12/2008; 43(6):1952-74. DOI: 10.1111/j.1475-6773.2008.00871.x
Source: PubMed

ABSTRACT To examine 9-year outcomes of implementation of short-term quality improvement (QI) programs for depression in primary care.
Depressed primary care patients from six U.S. health care organizations.
Group-level, randomized controlled trial.
Patients were randomly assigned to short-term QI programs supporting education and resources for medication management (QI-Meds) or access to evidence-based psychotherapy (QI-Therapy); and usual care (UC). Of 1,088 eligible patients, 805 (74 percent) completed 9-year follow-up; results were extrapolated to 1,269 initially enrolled and living. Outcomes were psychological well-being (Mental Health Inventory, five-item version [MHI5]), unmet need, services use, and intermediate outcomes.
At 9 years, there were no overall intervention status effects on MHI5 or unmet need (largest F (2,41)=2.34, p=.11), but relative to UC, QI-Meds worsened MHI5, reduced effectiveness of coping and among whites lowered tangible social support (smallest t(42)=2.02, p=.05). The interventions reduced outpatient visits and increased perceived barriers to care among whites, but reduced attitudinal barriers due to racial discrimination and other factors among minorities (smallest F (2,41)=3.89, p=.03).
Main intervention effects were over but the results suggest some unintended negative consequences at 9 years particularly for the medication-resource intervention and shifts to greater perceived barriers among whites yet reduced attitudinal barriers among minorities.


Full-text (2 Sources)

Available from
May 15, 2014